carvedilol has been researched along with Asthma in 5 studies
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The authors searched the English literature from 1984 to July 2010 via PubMed, EMBASE and SCOPUS using the following search terms: "cocaine-induced myocardial infarction AND treatment," "cocaine AND carvedilol," "beta blockers AND asthma," and "carvedilol AND asthma." | 8.87 | Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma. ( Mancell, J; Rogers, ML; Self, T; Soberman, JE, 2011) |
| "Patients with CHF and COPD tolerated carvedilol well with no significant reversible airflow limitation, but patients with CHF and asthma tolerated carvedilol poorly." | 7.71 | Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. ( Arnold, RH; Glanville, AR; Keogh, AM; Kotlyar, E; Macdonald, PS; McCaffrey, DJ, 2002) |
| "The authors searched the English literature from 1984 to July 2010 via PubMed, EMBASE and SCOPUS using the following search terms: "cocaine-induced myocardial infarction AND treatment," "cocaine AND carvedilol," "beta blockers AND asthma," and "carvedilol AND asthma." | 4.87 | Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma. ( Mancell, J; Rogers, ML; Self, T; Soberman, JE, 2011) |
| "We tested the non-selective β-blockers, carvedilol and nadolol, in house dust mite (HDM) driven murine asthma models where drugs were administered both pre- and post-development of the asthma phenotype." | 3.85 | Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype. ( Bond, RA; Eikenburg, DC; Joshi, R; Kim, H; Knoll, BJ; Valdez, D, 2017) |
| "We used mice with no detectable systemic adrenaline (PNMT(-/-) ) and wild-type (WT) mice to study the effects of four β-blockers, alprenolol, carvedilol, propranolol and nadolol, in an ovalbumin sensitization and challenge (Ova S/C) murine model of asthma." | 3.81 | β-Blockers have differential effects on the murine asthma phenotype. ( Bond, RA; Bouvier, M; Forkuo, GS; Joshi, R; Knoll, BJ; Leff, P; Parra, S; Thanawala, VJ; Valdez, DJ, 2015) |
| "Patients with CHF and COPD tolerated carvedilol well with no significant reversible airflow limitation, but patients with CHF and asthma tolerated carvedilol poorly." | 3.71 | Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma. ( Arnold, RH; Glanville, AR; Keogh, AM; Kotlyar, E; Macdonald, PS; McCaffrey, DJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, R | 2 |
| Valdez, D | 1 |
| Kim, H | 1 |
| Eikenburg, DC | 1 |
| Knoll, BJ | 2 |
| Bond, RA | 3 |
| Thanawala, VJ | 1 |
| Valdez, DJ | 1 |
| Forkuo, GS | 1 |
| Parra, S | 1 |
| Bouvier, M | 1 |
| Leff, P | 1 |
| Knight, JM | 1 |
| Mak, G | 1 |
| Shaw, J | 1 |
| Porter, P | 1 |
| McDermott, C | 1 |
| Roberts, L | 1 |
| You, R | 1 |
| Yuan, X | 1 |
| Millien, VO | 1 |
| Qian, Y | 1 |
| Song, LZ | 1 |
| Frazier, V | 1 |
| Kim, C | 1 |
| Kim, JJ | 1 |
| Milner, JD | 1 |
| Zhang, Y | 1 |
| Mandal, PK | 1 |
| Luong, A | 1 |
| Kheradmand, F | 1 |
| McMurray, JS | 1 |
| Corry, DB | 1 |
| Self, T | 1 |
| Rogers, ML | 1 |
| Mancell, J | 1 |
| Soberman, JE | 1 |
| Kotlyar, E | 1 |
| Keogh, AM | 1 |
| Macdonald, PS | 1 |
| Arnold, RH | 1 |
| McCaffrey, DJ | 1 |
| Glanville, AR | 1 |
1 review available for carvedilol and Asthma
| Article | Year |
|---|---|
Carvedilol therapy after cocaine-induced myocardial infarction in patients with asthma.
Topics: Adrenergic beta-1 Receptor Antagonists; Asthma; Carbazoles; Carvedilol; Clinical Trials as Topic; Co | 2011 |
4 other studies available for carvedilol and Asthma
| Article | Year |
|---|---|
Effects of β-blockers on house dust mite-driven murine models pre- and post-development of an asthma phenotype.
Topics: Adrenergic beta-Antagonists; Animals; Asthma; Carbazoles; Carvedilol; Disease Models, Animal; Inflam | 2017 |
β-Blockers have differential effects on the murine asthma phenotype.
Topics: Adrenergic beta-Antagonists; Allergens; Alprenolol; Animals; Asthma; Bronchoalveolar Lavage Fluid; C | 2015 |
Long-Acting Beta Agonists Enhance Allergic Airway Disease.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Animals; Anti-Asthmatic Agents; Arrestins; Aspergill | 2015 |
Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Asthma; Carbazoles; Carvedilol; Chi-Square Distribution; C | 2002 |